PubRank

Therapeutic advances in chronic disease (Ther Adv Chronic Dis)

Journal PubWeight™ 130.83‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Therapeutic advances in the treatment of nicotine addiction: present and future. 2010 1.42
2 Achieving appropriate regulations for electronic cigarettes. 2014 1.28
3 Evidence for a protective effect of polyphenols-containing foods on cardiovascular health: an update for clinicians. 2012 1.07
4 Update on the therapy of Behçet disease. 2014 1.01
5 New findings in osteoarthritis pathogenesis: therapeutic implications. 2013 1.00
6 Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance. 2013 0.99
7 Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review. 2015 0.98
8 A comparative bioavailability study of two formulations of pregabalin in healthy Chilean volunteers. 2010 0.95
9 Rifaximin in irritable bowel syndrome: rationale, evidence and clinical use. 2013 0.95
10 Treating pulmonary arterial hypertension: current treatments and future prospects. 2011 0.93
11 Cognitive dysfunction with aging and the role of inflammation. 2011 0.92
12 Pegylated interferon and ribavirin treatment for hepatitis C virus infection. 2011 0.91
13 Early onset type 2 diabetes: risk factors, clinical impact and management. 2014 0.91
14 Recent advances in treating multiple sclerosis: efficacy, risks and place in therapy. 2013 0.90
15 First-line natalizumab in multiple sclerosis: rationale, patient selection, benefits and risks. 2014 0.90
16 Radiation-induced small bowel disease: latest developments and clinical guidance. 2014 0.90
17 Optimal treatment of laryngopharyngeal reflux disease. 2013 0.90
18 Beyond interferon: rationale and prospects for newer treatment paradigms for chronic hepatitis C. 2015 0.89
19 Aliskiren: review of efficacy and safety data with focus on past and recent clinical trials. 2013 0.88
20 Pneumothorax: a tale of pain or spontaneity. 2014 0.88
21 Prospects for treating osteoarthritis: enzyme-protein interactions regulating matrix metalloproteinase activity. 2012 0.88
22 The diagnosis and treatment of chronic migraine. 2015 0.88
23 Glaucoma management: relative value and place in therapy of available drug treatments. 2014 0.87
24 Pharmacotherapy for obesity: novel agents and paradigms. 2014 0.87
25 Effects of vitamin d on muscle function and performance: a review of evidence from randomized controlled trials. 2011 0.87
26 Optimizing the use of thiopurines in inflammatory bowel disease. 2015 0.87
27 HIV stroke risk: evidence and implications. 2013 0.86
28 The future role of gut hormones in the treatment of obesity. 2014 0.86
29 Treatment of painful diabetic neuropathy. 2015 0.86
30 Reducing vascular events risk in patients with dyslipidaemia: an update for clinicians. 2011 0.85
31 A review of ultrabrief pulse width electroconvulsive therapy. 2012 0.85
32 Asenapine in bipolar I disorder: evidence and place in patient management. 2013 0.85
33 Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy. 2016 0.85
34 Obstructive sleep apnoea syndrome and its management. 2015 0.84
35 Bedaquiline for the treatment of multidrug-resistant tuberculosis: great promise or disappointment? 2015 0.84
36 Frontiers in Alzheimer's disease therapeutics. 2011 0.84
37 Sevelamer for hyperphosphataemia in kidney failure: controversy and perspective. 2012 0.84
38 Prevention of infection caused by immunosuppressive drugs in gastroenterology. 2013 0.83
39 The emerging role of epigenetics in cardiovascular disease. 2014 0.83
40 Teriflunomide in relapsing multiple sclerosis: therapeutic utility. 2013 0.83
41 Montelukast in asthma: a review of its efficacy and place in therapy. 2011 0.83
42 Strategies for preventing type 2 diabetes: an update for clinicians. 2013 0.83
43 The management of refractory coeliac disease. 2013 0.83
44 Vedolizumab: an α4β7 integrin antagonist for ulcerative colitis and Crohn's disease. 2015 0.83
45 Aflibercept in wet age-related macular degeneration: a perspective review. 2012 0.83
46 Chronic obstructive pulmonary disease: an update of treatment related to frequently associated comorbidities. 2010 0.83
47 Cardiovascular impact of drugs used in the treatment of diabetes. 2014 0.82
48 Age-related macular degeneration: current treatment and future options. 2011 0.82
49 Bisphosphonates for the treatment of osteoporosis: insights for clinicians. 2010 0.82
50 The potential for NX-1207 in benign prostatic hyperplasia: an update for clinicians. 2011 0.82
Next 50